HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FH-Pyrgos: a novel mutation in the promoter (-45delT) of the low-density lipoprotein receptor gene associated with familial hypercholesterolemia.

Abstract
In a patient with familial hypercholesterolemia (FH), we have identified a new mutation (-45delT) in repeat 3 of the low-density lipoprotein receptor (LDLR) gene promoter. Analysis of a neutral polymorphism in the LDLR mRNA from the patient's white blood cells showed that the expression of one allele was significantly reduced, and cells have only 24% of LDLR activity by binding and uptake of DiI-LDL. Transient transfection studies using a luciferase gene reporter revealed that the -45delT mutation considerably reduces the transcriptional activity of the LDLR promoter and strongly suggest that the mutation is the cause of the FH phenotype.
AuthorsG V Z Dedoussis, C Pitsavos, D Kelberman, J Skoumas, M E Prassa, D M Choumerianou, C Stefanadis, S E Humphries, P Toutouzas
JournalClinical genetics (Clin Genet) Vol. 64 Issue 5 Pg. 414-9 (Nov 2003) ISSN: 0009-9163 [Print] Denmark
PMID14616764 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, LDL
Topics
  • Adolescent
  • Adult
  • Aged
  • Alleles
  • Base Sequence
  • Female
  • Gene Expression
  • Humans
  • Hyperlipoproteinemia Type II (genetics)
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Mutation
  • Pedigree
  • Polymorphism, Genetic
  • Promoter Regions, Genetic
  • Receptors, LDL (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: